Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Avita Medical Ltd (RCEL)

Avita Medical Ltd (RCEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 496,464
  • Shares Outstanding, K 21,623
  • Annual Sales, $ 14,260 K
  • Annual Income, $ -42,030 K
  • 60-Month Beta 1.18
  • Price/Sales 33.49
  • Price/Cash Flow N/A
  • Price/Book 7.27
Trade RCEL with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.34
  • Number of Estimates 2
  • High Estimate -0.34
  • Low Estimate -0.35
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.54 +10.64%
on 11/02/20
23.85 -9.35%
on 11/09/20
+1.14 (+5.57%)
since 10/30/20
3-Month
19.54 +10.64%
on 11/02/20
29.34 -26.31%
on 09/18/20
-3.74 (-14.75%)
since 08/28/20
52-Week
19.54 +10.64%
on 11/02/20
55.35 -60.94%
on 02/19/20
-21.28 (-49.60%)
since 11/29/19

Most Recent Stories

More News
Reasons to Add Acadia Healthcare (ACHC) to Your Portfolio

Better-than-expected Q3 results, positive estimate revisions, high demand for services, bed expansion, business streamlining make Acadia Healthcare (ACHC) an attractive investment bet.

CYH : 8.18 (-2.62%)
HCA : 150.11 (-1.92%)
ACHC : 42.45 (-1.69%)
RCEL : 21.62 (-5.84%)
4 Sector ETFs & Stocks to Buy on Forecast-Beating Jobs Data

The U.S. economy added 1.76 million jobs in July 2020, down from a record 4.8 million in the previous month. However, the reading beat market expectations of a 1.6 million increase.

DPZ : 392.57 (+0.54%)
GTLS : 103.36 (-3.78%)
XLI : 88.03 (-0.89%)
XLV : 109.74 (+0.27%)
SPWH : 13.93 (-4.59%)
PEJ : 36.98 (-1.39%)
RCEL : 21.62 (-5.84%)
Encompass Health to Build Rehabilitation Hospital in Illinois

Encompass Health (EHC) plans to build a rehabilitation facility in Illinois to serve the local community. The healthcare home will be launched in 2022 spring and complement other units in the area.

DGX : 123.98 (-0.66%)
ADUS : 99.25 (+3.12%)
EHC : 80.58 (-1.55%)
RCEL : 21.62 (-5.84%)
AVITA Medical Files RECELL(R) System Investigational Device Exemption (IDE) Application with the U.S. Food and Drug Administration for Treatment of Vitiligo

AVITA Medical Limited (ASX: AVH) (NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, today announced that...

AVMXY : 7.8900 (+9.13%)
AVH : 0.8800 (+4.38%)
RCEL : 21.62 (-5.84%)
Hospital Industry's Dull Near-Term Outllook Induced by Coronavirus

Hospital Industry's Dull Near-Term Outllook Induced by Coronavirus

THC : 31.43 (-4.41%)
RCEL : 21.62 (-5.84%)
HCA : 150.11 (-1.92%)
CYH : 8.18 (-2.62%)
AMED : 244.79 (+1.71%)
ACHC : 42.45 (-1.69%)
AVITA Medical to Participate at the Jefferies Virtual Healthcare Conference

AVITA Medical Limited (Company) (ASX:AVH) (NASDAQ:RCEL) today announced that management will present virtually at the upcoming Jefferies Virtual Health Conference on Wednesday, June 3, 2020 at 4:30 p.m....

AVMXY : 7.8900 (+9.13%)
AVH : 0.8800 (+4.38%)
RCEL : 21.62 (-5.84%)
AVITA Medical to Participate at Oppenheimer's MedTech Summit

AVITA Medical Limited (Company) (ASX:AVH) (NASDAQ:RCEL) today announced that management will participate virtually in the 1-on-1 meetings at the upcoming Oppenheimer's MedTech Summit on Wednesday, May...

AVMXY : 7.8900 (+9.13%)
AVH : 0.8800 (+4.38%)
RCEL : 21.62 (-5.84%)
AVITA Medical Limited Proposed Redomiciliation to the United States of America - Registration of Scheme Booklet with ASIC and Financial Reporting Relief Granted by ASIC

AVITA Medical Limited (Company) (ASX:AVH) (NASDAQ:RCEL) is pleased to announce that the Australian Securities and Investments Commission (ASIC) has registered the scheme booklet (Scheme Booklet) in relation...

AVMXY : 7.8900 (+9.13%)
AVH : 0.8800 (+4.38%)
RCEL : 21.62 (-5.84%)
First Patient Enrolled in AVITA Medical's Pivotal Study Evaluating RECELL(R) System for Pediatric Scald Injuries

AVITA Medical Limited (ASX: AVH) (NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today the...

AVMXY : 7.8900 (+9.13%)
AVH : 0.8800 (+4.38%)
RCEL : 21.62 (-5.84%)
AVITA Medical to Attend the 2020 BTIG Healthcare Conference

AVITA Medical (ASX: AVH) (NASDAQ: RCEL), a global regenerative medicine company, announced that management will attend the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference from...

AVMXY : 7.8900 (+9.13%)
MHMNF : 54.5000 (unch)
AVH : 0.8800 (+4.38%)
RCEL : 21.62 (-5.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AVITA Therapeutics, Inc. is a regenerative medicine company with a technology platform to address unmet medical needs in burns, chronic wounds and aesthetics indications. AVITA Therapeutics Inc., formerly known as AVITA Medical Limited, is based in Valencia, United States.

See More

Key Turning Points

2nd Resistance Point 22.83
1st Resistance Point 22.23
Last Price 21.62
1st Support Level 21.28
2nd Support Level 20.93

See More

52-Week High 55.35
Fibonacci 61.8% 41.67
Fibonacci 50% 37.44
Fibonacci 38.2% 33.22
Last Price 21.62
52-Week Low 19.54

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar